Ultragenyx Pharmaceutical, Inc. (RARE)
21.47
-0.33
(-1.51%)
USD |
NASDAQ |
Mar 05, 16:00
21.47
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Cash from Investing (Quarterly) : -72.25M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -11.84M |
| Johnson & Johnson | -4.485B |
| CorMedix, Inc. | -291.32M |
| Apellis Pharmaceuticals, Inc. | -0.108M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -99.83M |
| Cash from Financing (Quarterly) | 394.19M |
| Free Cash Flow | -487.00M |
| Free Cash Flow Per Share (Quarterly) | -1.009 |
| Free Cash Flow to Equity (Quarterly) | -489.65M |
| Free Cash Flow to Firm (Quarterly) | -81.62M |
| Free Cash Flow Yield | -23.00% |